EG12014
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EG12014, covering 2017-06-08 to 2023-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer [Phase 3]